Imaging in women

Clinical Nuclear Cardiology

Volumn , Issue , 2010, Pages 425-436

  Polk, Donna M ^a   Ford Mukkamala, Laura ^b   Heller, Gary V ^c  

^a HARTFORD HOSPITAL   (United States)

^b BILLINGS CLINIC   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882511957     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-05796-7.00044-8     Document Type: Chapter

References (88)

1. Heart Disease and Stroke Statistics-2004 Update 2004, American Heart Association and National Center on Health Statistics, National Heart, Lung and Blood Institute, Dallas, TX.
2. Vaccarino V, Krumholz HM, Yarzebski J, Gore JM, Goldberg RJ: Sex differences in 2-year mortality after hospital discharge for myocardial infarction, Ann Intern Med 134:173-181.
3. Robinson K., Conroy R.M., Mulcahy R., Hickey N. The 15-year prognosis of a first acute coronary episode in women. Eur Heart J 1992, 13:67-69.
4. Mosca L., Ferris A., Fabunmi R., Robertson R.M. Tracking women's awareness of heart disease: An American Heart Association National Study. Circulation 2004, 190:573-579.
5. Lerner D.J., Kannel W.B. Patterns of coronary artery disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986, 111:383-390.
6. Hochman J.S., McCabe C.H., Stone P.H., et al. Outcome and profile of women and men presenting with acute coronary syndromes: A report from TIMI IIIB. J Am Coll Cardiol 1997, 30:141-148.
7. Hochman J.S., Tamis J.E., Thompson T.D., et al. Sex, clinical presentation and outcome in patients with acute coronary syndromes. N Engl J Med 1999, 341:226-232 1.
8. Marrugat J., Sala J., Malia R., et al. Mortality differences between men and women following first myocardial infarction. JAMA 1998, 2801:1405-1409.
9. Chang W.C., Kaul P., Westerhout C.M., et al. Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina. Arch Intern Med 2003, 163:2476-2484.
10. Shaw L.J., Shaw R.E., Radford M., et al. Sex and ethnic differences in the prevalence of significant and severe coronary artery disease in the ACC-National Cardiovascular Data Registry. Circulation 2004, 110. for the ACC-National Cardiovascular Data Registry, SIII800.
11. Rollman G.B., Lauterbacher S., Jones K.S. Sex and gender differences in responses to experimentally induced pain in humans. Sex, Gender and Pain 2001, vol 17. International Association for the Study of Pain, Seattle. R.B. Fillingham (Ed.).
12. Sheps D.S., McMahon R.P., Light K.C., et al. Low hot pain threshold predicts shorter time to exercise-induced angina: results from the psychophysiological investigations of myocardial ischemia (PIMI) study. J Am Coll Cardiol 1999, 33:1855-1862.
13. Milner K.A., Funk M., Richards S., Wilmes R.M., Vaccarino V., Krumholz H.M. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol 1999, 84:396-399.
14. Culic V., Eterovic D., Dinko M., Rumboldt Z., Izet H. Gender differences in triggering of acute myocardial infarction. Am J Cardiol 2000, 85:753-756.
15. Goldberg R.J., O'Donnell C., Yarzebski J., Bigelow C., Savageau J., Gore J.M. Sex differences in symptom presentation associated with acute myocardial infarction: A population-based perspective. Am Heart J 1998, 136:189-195.
16. Kudenchuk P.J., Maynard C., Martin J.S., Wirkus M., Weaver W.D. Comparison of presentation, treatment and outcomes of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry). Am J Cardiol 1996, 78:9-14.
17. McSweeney J.C., Cody M., O'Sullivan P., Elberson K., Moser D.K., Garvin B.J. Women's early warning symptoms of acute myocardial infarction. Circulation 2004, 108:2619-2623.
18. Manolio T.A., Pearson T.A., Wenger N.K., Barrett-Connor E., Payne G.H., Harlan W.H. Cholesterol and heart disease in older persons and women: Review of an NHLBI workshop. Ann Epidemiol 1992, 2:161-176.
19. Stamier J., Wentworth D., Neaton J.D. for the MRFIT Research Group: Is relationship between serum cholesterol and risk for premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986, 256:2823-2828.
20. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977, 62:707-714.
21. Castelli W.P. Cholesterol and lipids in the risk of coronary artery disease- the Framingham Heart Study. Can J Cardiol 1988, 4:5A-10A.
22. Gordon D.J., Probstfield J.L., Barrison R.J., et al. High-density lipoprotein cholesterol and cardiovascular disease in men and women. Four prospective American studies. Circulation 1989, 79:8-15.
23. Stevenson J.C., Crook D., Godsland I.F. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993, 98:83-90.
24. Jenner J.L., Ordovas J.M., Lamon-Fava S., et al. Effects f age, sex and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation 1993, 87:1135-1141.
25. Hu F.B., Stampfer M.J., Solomon C.G., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women. Arch Intern Med 2001, 161:1717-1723.
26. Ford E.S., Giles W.H., Dietz Wh Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
27. Marroquin O.C., Kip K.E., Kelley D.E., et al. for the Women's Ischemia Syndrome Evaluation Investigators: Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: A report from the Women's Ischemia Syndrome Evaluation. Circulation 2004, 109:714-721.
28. Survey by ADA and AHA 2001.
29. Al Delaimy W.K., Willett W.C., Manson J.E., et al. Smoking and mortality among women with type 2 diabetes: The Nurses' Health Study cohort. Diabetes Care 2001, 24(12):2043-2048.
30. Al Delaimy W.K., Manson J.E., Solomon C.G., et al. Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 2002, 162(3):273-279.
31. Diamond G.A., Forrester J.S. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979, 300(24):1350-1358.
32. Shaw L.J., Bairey Merz C.N., Pepine C.J., et al. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part I: Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006, 47:S4-S20.
33. Reis S.E., Holubkov R., Conrad Smith A.J., et al. Coronary microvascular dysfunction in women is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 2001, 141:735-741.
34. Santana-Boado C., Candell-Riera J., Castell-Conesa J., et al. Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men [commentary]. J Nucl Med 1998, 39(5):751-755.
35. Kwok Y., Kim C., Grady D., et al. Meta-analysis of exercise testing to detect coronary artery disease in women [commentary]. Am J Cardiol 1999, 83(5):660-666.
36. Arruda-Olson A.M., Juracan E.M., Mahoney D.W., et al. Prognostic value of exercise echocardiography in 5,798 patients: Is there a gender difference?. J Am Coll Cardiol 2002, 39(4):625-631.
37. Friedman T.D., Greene A.C., Iskandrian A.S., et al. Exercise thallium-201 myocardial scintigraphy in women: Correlation with coronary arteriography. Am J Cardiol 1982, 49(7):1632-1637.
38. Mieres J.H., Shaw L.J., Hendel R.C., et al. A report of the American Society of Nuclear Cardiology Task Force on Women and Heart Disease (writing group on perfusion imaging in women). J Nucl Cardiol 2003, 10(1):95-101.
39. Schmermund A., Erbel R., Silber S. Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2,030 persons with no symptoms of coronary artery disease. Am J Cardiol 2002, 90(2):168-173.
40. Taillefer R., DePuey E.G., Udelson J.E., et al. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997, 29(1):69-77.
41. White M.P. Pharmacologic stress testing: Understanding the options. J Nucl Cardiol 1999, 6(6):672-675.
42. Morise A.P., Dalal J.N., Duval R.D. Value of a simple measure of estrogen status for improving the diagnosis of coronary artery disease in women. Am J Med 1993, 94(5):491-496.
43. Mieres J.H., Shaw L.J., Hendel R.C., et al. The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN? A multi-center, prospective, randomized study to establish the optimal method for detection of coronary artery disease (CAD) risk in women at an intermediate-high pretest likelihood of CAD: study design. J Nucl Cardiol 2009, 16:105-112.
44. Lakoski S.G., Greenland P., Wong N.D., et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score. The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2007, 167(22):2437-2442.
45. Nesto R.W., Phillips R.T., Kett K.G., et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy [erratum appears in Ann Intern Med 108(4):646, 1988]. Ann Intern Med 1988, 108(2):170-175.
46. Alexander K.P., Shaw L.J., Shaw L.K., et al. Value of exercise treadmill testing in women [erratum appears in J Am Coll Cardiol 1999 Jan;33(1):289]. J Am Coll Cardiol 1998, 32(6):1657-1664.
47. Okin P.M., Kligfield P. Gender-specific criteria and performance of the exercise electrocardiogram. Circulation 1995, 92(5):1209-1216.
48. Gibbons R.J., Balady G.J., Bricker J.T., et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002, 40(8):1531-1540.
49. Wessel T.R., ARant C.V., Olson M.B., et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA 2004, 292:1179-1187.
50. Gulati M., Pandy D.K., Arnsdorf M.F., et al. Exercise capacity and the risk of death in women: the St. James Women Take Heart Project. Circulation 2003, 108:1554-1559.
51. Goodgold H.M., Rehder J.G., Samuels L.D., et al. Improved interpretation of exercise Tl-201 myocardial perfusion scintigraphy in women: Characterization of breast attenuation artifacts. Radiology 1987, 165(2):361-366.
52. Stratmann H.G., Williams G.A., Wittry M.D., et al. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 1994, 89(2):615-622.
53. Heller G.V., Ahmed I., Tilkemeier P.L., et al. Comparison of chest pain, electrocardiographic changes, and thallium-201 scintigraphy during varying exercise intensities in men with stable angina pectoris. Am J Cardiol 1999, 68:569-574.
54. Heller G.V., Ahmed I., Tilkemeier P.L., et al. Influence of exercise intensity upon the presence, distribution and size of thallium-201 defect. Am Heart J 1992, 123:909-916.
55. Navare S.M., Kapetanopoulos A., Heller G.V. Pharmacologic radionuclide myocardial perfusion imaging. Curr Cardiol Rep 2003, 5(1):16-24.
56. Amanullah A.M., Kiat H., Friedman J.D., et al. Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: Diagnostic efficacy in detection of coronary artery disease. J Am Coll Cardiol 1996, 27(4):803-809.
57. Travin M.I., Katz M.S., Moulton A.W., et al. Accuracy of dipyridamole SPECT imaging in identifying individual coronary stenoses and multivessel disease in women versus men. J Nucl Cardiol 2000, 7(3):213-220.
58. Shehata A.R., Gillam L.D., Mascitelli V.A., et al. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial profusion imaging and echocardiography. Am J Cardiol 1997, 80:268-272.
59. Leppo J.A. Comparison of pharmacologic steroagents. J Nucl Cardiol 1996, 3(6 Pt 2):522-526.
60. Hansen C.L., Crabbe D., Rubin S. Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: An effect of smaller chamber size. J Am Coll Cardiol 1996, 28(5):1214-1219.
61. Hayes S.W., De Lorenzo A., Hachamovitch R., et al. Prognostic implications of combined prone and supine acquisitions in patients with equivocal or abnormal supine myocardial perfusion SPECT. J Nucl Med 2003, 44:1633-1640.
62. Bateman T.M., Heller G.V., Johnson L.L., et al. Does attenuation correction add value to non-attenuation corrected ECG-gated technetium-99m sestamibi SPECT? [abstract]. J Nucl Cardiol 2003, 10:S91.
63. Links J.M., DePuey E.G., Taillefer R., et al. Attenuation correction and gating synergistically improve the diagnostic accuracy of myocardial perfusion SPECT. J Nucl Cardiol 2002, 9(2):183-187.
64. Iskandrian A.E., Heo J., Nallamothu N. Detection of coronary artery disease in women with use of stress single-photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol 1997, 4(4):329-335.
65. Iskander S., Iskandrian A.E. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998, 32(1):57-62.
66. Gibbons R.J., Hodge D.O., Berman D.S., et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999, 100(21):2140-2145.
67. Heller G.V., Herman S.D., Travin M.I., et al. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995, 26(5):1202-1208.
68. Galassi A.R., Azzarelli S., Tomaselli A., et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease. Am J Cardiol 2001, 88(2):101-106.
69. Vanzetto G., Ormezzano O., Fagret D., et al. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: Study in 1137 patients with 6-year follow-up. Circulation 1999, 100(14):1521-1527.
70. Ladenheim M.L., Pollock B.H., Rozanski A., et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986, 7(3):464-471.
71. Pancholy S.B., Fattah A.A., Kamal A.M., et al. Independent and incremental prognostic value of exercise thallium single-photon emission computed tomographic imaging in women. J Nucl Cardiol 1995, 2(2 Pt 1):110-116.
72. Marwick T.H., Shaw L.J., Lauer M.S., et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 1999, 106(2):172-178.
73. O'Keefe J.H., Bateman T.M., Ligon R.W., et al. Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease [commentary]. J Nucl Cardiol 1998, 5(1):28-33.
74. Cacciabaudo J.M., Hachamovitch R. Stress myocardial perfusion SPECT in women: Is it the cornerstone of the noninvasive evaluation? [commentary]. J Nucl Med 1998, 39(5):756-759.
75. Hachamovitch R., Berman D.S., Kiat H., et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: Gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996, 28(1):34-44.
76. Machecourt J., Longere P., Fagret D., et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 1994, 23(5):1096-1106.
77. Stratmann H.G., Tamesis B.R., Younis L.T., et al. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994, 73(9):647-652.
78. Amanullah A.M., Kiat H., Hachamovitch R., et al. Impact of myocardial perfusion single-photon emission computed tomography on referral to catheterization of the very elderly. Is there evidence of gender-related referral bias. J Am Coll Cardiol 1996, 28(3):680-686.
79. Travin M.I., Duca M.D., Kline G.M., et al. Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m sestamibi myocardial single-photon emission computed tomography scintigraphy. Am Heart J 1997, 134(1):73-82.
80. Barrett-Connor E.L., Cohn B.A., Wingard D.L., et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. [erratum appears in JAMA 1991 Jun 26;265(24):3249]. JAMA 1991, 265(5):627-631.
81. America Y.G., Bax J.J., Boersma E., et al. The additive prognostic value of perfusion and functional data assessed by quantitative gated SPECT in women. J Nucl Cardiol 2009, 16:10-19.
82. Wexler O., Yoder S.R., Elder J.L., et al. Effect of gender on cardiovascular risk stratification with ECG gated SPECT left ventricular volume indices and ejection fraction. J Nucl Cardiol 2009, 16:28-37.
83. Heyden S., Heiss G., Bartel A.G., et al. Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chron Dis 1980, 33(5):265-273.
84. Kannel W.B., McGee D.L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study. Diabetes Care 1979, 2(2):120-126.
85. Pan W.H., Cedres L.B., Liu K., et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986, 123(3):504-516.
86. Giri S., Shaw L.J., Murthy D.R., et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002, 105(1):32-40.
87. Berman D.S., Kang X., Hayes S.W., et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003, 41(7):1125-1133.
88. Mora S., Redberg R., Cui Y., et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: A 20 year follow-up of the Lipid Research Clinics Prevalence Study. JAMA 2003, 290:1600-1607.